ML20137R444

Concurs W/Proposed Rev to 10CFR35,subj to Listed Comments Re Definition of Term Confinement, Bioassays After I-131 Administration & Typos

ML20137R444
Person / Time
Issue date:	07/27/1984
From:	Scarano R NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION V)
To:	Cunningham R NRC OFFICE OF NUCLEAR MATERIAL SAFETY & SAFEGUARDS (NMSS)
Shared Package
ML20136D915	List: ML20136D909 ML20136E266 ML20136E272 ML20136E278 ML20136E295 ML20136E318 ML20136E323 ML20136E492 ML20136E705 ML20136E879 ML20136F099 ML20136F109 ML20136F154 ML20137Q526 ML20137Q531 ML20137Q538 ML20137Q545 ML20137Q557 ML20137Q566 ML20137Q572 ML20137Q579 ML20137Q585 ML20137Q596 ML20137Q605 ML20137Q612 ML20137Q619 ML20137Q628 ML20137Q633 ML20137Q639 ML20137Q644 ML20137Q650 ML20137Q655 ML20137Q660 ML20137Q668 ML20137Q671 ML20137Q676 ML20137Q682 ML20137Q686 ML20137Q688 ML20137Q690 ML20137Q692 ML20137Q695 ML20137Q697 ML20137Q705 ML20137Q710 ML20137Q715 ML20137Q719 ML20137Q721 ML20137Q724 ML20137Q726 ... further results
References
FRN-50FR30616, RULE-PR-35 AA73-1, NUDOCS 8509230516
Download: ML20137R444 (1)

Text

b s Ji,w 1h4. rMg

'o UNITED STATES p]j E

NUCLEAR REGULATOllY COMMISSION

()

?, '

/g REGION V O,

a 1450 MARIA LANE, SUITE 210 I

l E

WALNUT CREEK, CALIFORNIA 94596 J

JUL 2 7 B84 t'

Memorandum For:

Richard E. Cunningham, Director Division of Fuel Cycle and Material Safety From:

Ross A. Scarano, Director Division of Radiological Safety and Safeguards Programs

Subject:

Concurrence and Comments on Proposed Revision of 10 CFR Part 35

~

We concur on the proposed revision of 10 CFR Part 35 with the following comments:

1.

35.75, " Release of patients containing radiopharmaceuticals or permanent /u v>MM implants" and 35.404, " Release of patients treated with temporary implanta" state that the licensee shall not authorize " release from iQ 36 e /

g'.

confinement for medical care..." patients who have received radiopharmaceutical or brachytherapy treatments unless certain conditions are met.

We feel that this section should be clarified so that urgent treatments requiring that the patient be moved from his or her private room (such as emergency surgery) are not hampered by this regulation.

This may be accomplished by defining the term " confinement" in the regulation.

2.

35.315(g) requires that each individual.who helped prepare a therapeutic d

dosage of iodine-131 shall have a bioassay conducted within three days.

fc MI Currently, bioassays are not required when iodine-131 is administered in[mhki capsule form'and the capsule is not dropped or crushed.

3.

We believe that a typographical error was made in 35.31(b)(1).

It

/

should read as follows: " Investigate overexposures, accidents,. spills, losses, thefts, unauthorized receipts, uses, transfers, and disposals, and other deviations of approved radiation safety practice and implement corrective actions as necessary;".

We appreciated the opportunity to comment on this proposed regulation.

A ~/<

/

Ross A. Scarano, Director Division of Radiological Safety and Safeguards Programs 8509230516 850906 PDR PR 35 SOFR30616 PDR

.